Moreover, the Slit2 axon guidance molecule, which has been characterized to have lower expression in primary glioma specimens and invasive glioma cells relative to non-neoplastic brain, was described as part of the Slit2-Robo1 axis that inhibited glioma invasion through attenuation of Cdc42 activity (88). This evidence concerns the gene NTNG1 and central nervous system cancer.